BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27429195)

  • 1. Epigenetic activation of MGAT3 and corresponding bisecting GlcNAc shortens the survival of cancer patients.
    Kohler RS; Anugraham M; López MN; Xiao C; Schoetzau A; Hettich T; Schlotterbeck G; Fedier A; Jacob F; Heinzelmann-Schwarz V
    Oncotarget; 2016 Aug; 7(32):51674-51686. PubMed ID: 27429195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of hepatic neoplasms is severely retarded in mice lacking the bisecting N-acetylglucosamine on N-glycans: evidence for a glycoprotein factor that facilitates hepatic tumor progression.
    Bhaumik M; Harris T; Sundaram S; Johnson L; Guttenplan J; Rogler C; Stanley P
    Cancer Res; 1998 Jul; 58(13):2881-7. PubMed ID: 9661906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of three gain-of-function CHO mutants that add the bisecting GlcNAc to N-glycans.
    Stanley P; Sundaram S; Tang J; Shi S
    Glycobiology; 2005 Jan; 15(1):43-53. PubMed ID: 15329358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status.
    Anugraham M; Jacob F; Nixdorf S; Everest-Dass AV; Heinzelmann-Schwarz V; Packer NH
    Mol Cell Proteomics; 2014 Sep; 13(9):2213-32. PubMed ID: 24855066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies that recognize bisected complex N-glycans on cell surface glycoproteins can be made in mice lacking N-acetylglucosaminyltransferase III.
    Lee J; Park SH; Stanley P
    Glycoconj J; 2002 Mar; 19(3):211-9. PubMed ID: 12815232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoproteomic analysis reveals the effects of bisecting GlcNAc in intrahepatic cholangiocarcinoma.
    Dan W; Li C; Li J; Li P; Xin M; Chen Z; Dang L; Yu Z; Li J; Shen J; Hu L; Sun S
    Glycoconj J; 2022 Dec; 39(6):737-745. PubMed ID: 36322335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisecting N-Acetylglucosamine on EGFR Inhibits Malignant Phenotype of Breast Cancer via Down-Regulation of EGFR/Erk Signaling.
    Cheng L; Cao L; Wu Y; Xie W; Li J; Guan F; Tan Z
    Front Oncol; 2020; 10():929. PubMed ID: 32612952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycomic analysis of membrane glycoproteins with bisecting glycosylation from ovarian cancer tissues reveals novel structures and functions.
    Allam H; Aoki K; Benigno BB; McDonald JF; Mackintosh SG; Tiemeyer M; Abbott KL
    J Proteome Res; 2015 Jan; 14(1):434-46. PubMed ID: 25437919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter methylation of the
    Klasić M; Markulin D; Vojta A; Samaržija I; Biruš I; Dobrinić P; Ventham NT; Trbojević-Akmačić I; Šimurina M; Štambuk J; Razdorov G; Kennedy NA; Satsangi J; Dias AM; Pinho S; Annese V; Latiano A; D'Inca R; ; Lauc G; Zoldoš V
    Clin Epigenetics; 2018; 10():75. PubMed ID: 29991969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation, characterization and inactivation of the mouse Mgat3 gene: the bisecting N-acetylglucosamine in asparagine-linked oligosaccharides appears dispensable for viability and reproduction.
    Priatel JJ; Sarkar M; Schachter H; Marth JD
    Glycobiology; 1997 Feb; 7(1):45-56. PubMed ID: 9061364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bisecting GlcNAc on N-glycans inhibits growth factor signaling and retards mammary tumor progression.
    Song Y; Aglipay JA; Bernstein JD; Goswami S; Stanley P
    Cancer Res; 2010 Apr; 70(8):3361-71. PubMed ID: 20395209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide Sequence Mapping around Bisecting GlcNAc-Bearing
    Ohkawa Y; Kizuka Y; Takata M; Nakano M; Ito E; Mishra SK; Akatsuka H; Harada Y; Taniguchi N
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445285
    [No Abstract]   [Full Text] [Related]  

  • 13. Loss and recovery of Mgat3 and GnT-III Mediated E-cadherin N-glycosylation is a mechanism involved in epithelial-mesenchymal-epithelial transitions.
    Pinho SS; Oliveira P; Cabral J; Carvalho S; Huntsman D; Gärtner F; Seruca R; Reis CA; Oliveira C
    PLoS One; 2012; 7(3):e33191. PubMed ID: 22427986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer.
    Zhang W; Barger CJ; Link PA; Mhawech-Fauceglia P; Miller A; Akers SN; Odunsi K; Karpf AR
    Epigenetics; 2015; 10(8):736-48. PubMed ID: 26098711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic analysis of sporadic and Lynch-associated ovarian cancers reveals histology-specific patterns of DNA methylation.
    Niskakoski A; Kaur S; Staff S; Renkonen-Sinisalo L; Lassus H; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
    Epigenetics; 2014 Dec; 9(12):1577-87. PubMed ID: 25625843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisecting GlcNAc modification stabilizes BACE1 protein under oxidative stress conditions.
    Kizuka Y; Nakano M; Kitazume S; Saito T; Saido TC; Taniguchi N
    Biochem J; 2016 Jan; 473(1):21-30. PubMed ID: 26467158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Regulation of the Homeobox Gene MSX1 Associates with Platinum-Resistant Disease in High-Grade Serous Epithelial Ovarian Cancer.
    Bonito NA; Borley J; Wilhelm-Benartzi CS; Ghaem-Maghami S; Brown R
    Clin Cancer Res; 2016 Jun; 22(12):3097-3104. PubMed ID: 26763252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The bisecting GlcNAc in cell growth control and tumor progression.
    Miwa HE; Song Y; Alvarez R; Cummings RD; Stanley P
    Glycoconj J; 2012 Dec; 29(8-9):609-18. PubMed ID: 22476631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival.
    Dai W; Teodoridis JM; Zeller C; Graham J; Hersey J; Flanagan JM; Stronach E; Millan DW; Siddiqui N; Paul J; Brown R
    Clin Cancer Res; 2011 Jun; 17(12):4052-62. PubMed ID: 21459799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced hepatocyte proliferation is the basis of retarded liver tumor progression and liver regeneration in mice lacking N-acetylglucosaminyltransferase III.
    Yang X; Tang J; Rogler CE; Stanley P
    Cancer Res; 2003 Nov; 63(22):7753-9. PubMed ID: 14633700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.